India's Serum institute to sell AstraZeneca vaccine to private hospitals at $8/dose


FILE PHOTO: Officials unload boxes containing vials of AstraZeneca's COVISHIELD, a coronavirus disease (COVID-19) vaccine manufactured by Serum Institute of India, outside a vaccination storage centre in Ahmedabad, India, January 12, 2021. REUTERS/Amit Dave

NEW DELHI (Reuters) - The Serum Institute of India said on Wednesday it would sell the AstraZeneca vaccine to the country's state governments at 400 rupees ($5.30) per dose and to private hospitals at 600 rupees ($7.95).

"Furthermore, owing to the complexity, and urgency of the situation it is challenging to supply it independently to each corporate entity," it said in a statement. "We would urge all corporate and private individuals to access the vaccines through the state facilitated machinery and private health systems."

($1 = 75.4620 Indian rupees)

(Reporting by Krishna N. Das and Euan Rocha, editing by Louise Heavens)

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3
   

Next In World

U.S. expresses 'serious concerns' about Jerusalem clashes, evictions of Palestinians
David Attenborough named COP26 People’s Advocate ahead of key climate summit
Six killed at southern Nigerian police station - spokesman
Afghan Taliban declares three-day ceasefire for Eid celebration this week -spokesman
Algeria to impose restrictions on street protests
Italian judge killed by Mafia is put on road to sainthood
Explainer-Jerusalem tense over evictions and holidays
Siberian doctor who treated Kremlin critic Navalny goes missing, police say
South Sudan president dissolves parliament in line with peace deal
Armenians rally in support of ex-president Kocharyan ahead of vote

Stories You'll Enjoy


Vouchers